Insider filing · EXEL
George Poste sold $2.7M of Exelixis (EXEL)
Executed May 7, disclosed May 8, 1 day later.
Value, as filed
$2.7M
60,000 sh × $45.71
Executed
May 7
the trade date, as filed
Disclosed
May 8
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GP
George Poste
Director
profile →
George Poste (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.7M of EXEL (60,000 sh × $45.71, as filed), executed May 7.
The name
EXEL
Exelixis, Inc.
EXEL · Healthcare · 53 filings in 24 months
ticker →
Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by George Poste in EXEL
EXELSALE
Exelixis, Inc.
$949K20,634 sh × $45.99
Exec May 16 2025
Filed May 16 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $551K
15,874 sh × $34.74
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $1.0M
30,000 sh × $34.00
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET